drugset / Trial / NCT03346837

A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

NCT03346837

Phase 1 Completed 53 enrolled Bristol-Myers Squibb
RandomizedParallel-groupOpen-labelOther

Summary

Assess the effects of itraconazole and rifampin on the pharmacokinetics, safety, and tolerability of BMS-986205.

Timeline

Start
2017-11-22
Primary completion
2017-12-20
Completion
2017-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject LINRODOSTAT Small molecule Oral
Subject Rifampin Small molecule Oral

Indications